Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 92 PS2-18-06 | DOI: 10.1530/endoabs.92.PS2-18-06

ETA2023 Poster Presentations Treatment 1 (9 abstracts)

Prognostic model of the rate and risk of papillary thyroid cancer local metastases based on preoperative clinical and ulrasonic predictors

Pavlo Lishchynskyi 1 , Oleksandr Tovkai 2 , Volodymyr Palamarchuk 1 , Sergii Zemskov 3 & Volodymyr Kuts 4


1Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of Moh of Ukraine, Endocrine Surgery, Kyiv, Ukraine; 2Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of Moh of Ukraine, Kyiv, Ukraine; 3Bogomolets National Medical University, Kyiv, Ukraine; 4National Institute of Phthisiology and Pulmonology Named after F.G. Yanovsky National Academy of Medical Sciences of Ukraine, Information and Computer Technologies, Kyiv, Ukraine


Introduction: Papillary thyroid cancer (PTC) is an indolent tumor with low malignancy potential. However, occult synchronous cervical lymph node metastases (CLNM), which may lead to a high risk of local recurrence, are still present in 20–40% of patients. The low diagnostic efficiency (< 47%) of the neck ultrasound in central lymph node metastases detection leads to the development of alternative ways of occult CLNM prediction in patients with PTC. The objective is to develop a prognostic model based on preoperative clinical and ultrasound predictors for the assessment of the papillary thyroid cancer local metastasis risk.

Materials and methods: The perioperative data of 301 patients were analyzed: 117 patients with CLNM, diagnosed after surgery; 184 patients - without CLNM. Five factors were determined as the most significant CLNM predictors: 1) subcapsular location; 2) tumor size; 3) ill-defined margin; 4) microcalcifications; 5) age. The prognostic model was created on the basis of binary logistic regression using the statistical analysis program StatPlus, version 7 (AnalystSoft Inc.). An MS Excel template was created to automate the calculation process.

Results: Regression coefficients calculations were performed:

The probability of metastases detection was calculated by the formula: P = 1/ (1 - e-y), where e - the Euler`s number, y - obtained by regression equation, i.e.: y = –2.009 – 0.039*X1 + 0.114*X2 + 1.033*X3 + 1.215*X4 + 0.590*X5 X are binary variables (presence or absence of the feature): X 1 - age (years), X 2 - tumor size (threshold value is ≥ 10 mm), X 3 - subcapsular location, X 4 - ill-defined margin, and X 5 - microcalcifications. The resulting prognostic model had sensitivity – 61.5 % (95% CI 52.1-70.4); specificity – 83.7 % (95% CI 77.6-88.7); diagnostic efficiency – 75.1 % (95% CI 69.8-79.9). The model`s quality was assessed (n =50): sensitivity – 53.7 %, specificity – 77.1 %, and diagnostic efficiency - 70.0%. The values of the selected indicators were within the calculated 95% CI. The values of the selected indicators were generally within the calculated 95% CI, however, the model needs further improvement on a larger sample size.

IndicatorRegression coefficient β
b 0-2,009
b 1-0,039
b 20,114
b 31,033
b 41,215
b 50,590

Conclusions: The practical application of the suggested prognostic model may improve the outcomes of PTC management by preoperative predicting the risk of CLNM presence with an accuracy of 75.1%.

Volume 92

45th Annual Meeting of the European Thyroid Association (ETA) 2023

European Thyroid Association 

Browse other volumes

Article tools

My recent searches

No recent searches.